|
27/02/2024 |
Jusvinza in adult patients with Rheumatoid Arthritis from Camaguey and Eastern Provinces |
CIGB_IB |
Registered |
|
23/12/2025 |
HeberNasvac in chronic hepatitis B viral infection in adult patients. Routine clinical practice study |
CIGB_IB |
Registered |
|
2012-07-20 |
T1h in severe psoriasis-expanded access program (PUCE) |
CIM |
Registered |
|
2010-12-03 |
1E10 anti-idiotype vaccine, metastatic colon, phase II. |
CIM |
Registered |
|
2010-12-24 |
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients |
CIM |
Registered |
|
2010-12-27 |
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
CIM |
Registered |
|
2010-12-28 |
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients |
CIM |
Registered |
|
2010-12-28 |
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients |
CIM |
Registered |
|
2010-12-28 |
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |
CIM |
Registered |
|
2010-12-28 |
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III. |
CIM |
Registered |
|
2010-12-29 |
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin. |
CIM |
Registered |
|
2010-12-29 |
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
CIM |
Registered |
|
2010-12-29 |
Patients with non small cells lung cancer (NSCLC) and brain metastasis. |
CIM |
Registered |
|
2010-12-29 |
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma. |
CIM |
Registered |
|
2010-12-29 |
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment. |
CIM |
Registered |
|
2010-12-29 |
14F7 MAb marked with Tc99 Phase II in breast tumors. |
CIM |
Registered |
|
2008-12-27 |
99mTc-marked 14F7 MaB in metastatic breast, phase II |
CIM |
Registered |
|
2010-12-27 |
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis |
CIM |
Registered |
|
2010-12-27 |
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
CIM |
Registered |
|
2010-12-27 |
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. |
CIM |
Registered |
